The Duke Human Vaccine Institute

The Duke Human Vaccine Institute (DHVI) is a non-profit research organization located in Durham, North Carolina. DHVI employs approximately 194 people and generates roughly $100 million in annual revenue. The institute is dedicated to combating major infectious diseases through the development of vaccines and therapeutics. DHVI's research focuses on overcoming key scientific challenges in developing vaccines and treatments for diseases such as HIV, influenza, and SARS-CoV-2. Their work plays a crucial role in the Global HIV/AIDS Vaccine Enterprise and makes significant contributions to addressing global health threats. DHVI is committed to innovation, collaboration, and excellence in its pursuit of developing solutions for global health challenges. The institute fosters a culture of respect, integrity, and safety, embracing change and diversity to achieve synergistic results. For more information about DHVI's research and mission, please visit their website at dhvi.duke.edu.